Astellas Pharma Inc.
Symbol: ALPMF
PNK
9.521
USDMarktpreis heute
204.6593
P/E-Verhältnis
-0.0691
PEG-Verhältnis
17.07B
MRK Kapital
- 0.00%
DIV Rendite
Astellas Pharma Inc. (ALPMF) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1587585 | 335687 | 396624 | 337283 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 102440 | 0 | 19784 | 21297 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 2039347 | 548036 | 446516 | 404001 | |||||||||||||||||||||
balance-sheet.row.inventory | 888590 | 248738 | 174386 | 153072 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 163520 | 62269 | 32428 | 28998 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 4679042 | 1194730 | 1049954 | 923354 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1170110 | 293742 | 286459 | 269044 | |||||||||||||||||||||
balance-sheet.row.goodwill | 1566168 | 418694 | 328411 | 303030 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 5029140 | 1453824 | 562496 | 623431 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6595308 | 1872518 | 890907 | 926461 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 462124 | 144421 | 145028 | 141206 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 233139 | 45594 | 84169 | 72331 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 139541 | 18598 | 1 | -1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 8600222 | 2374873 | 1406564 | 1409041 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.account-payables | 621308 | 185193 | 140236 | 130739 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1605013 | 472278 | 88546 | 157730 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 120932 | 38515 | 5137 | 32388 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1434596 | 447738 | 54217 | 676 | |||||||||||||||||||||
Deferred Revenue Non Current | 398707 | 0 | 121279 | 138943 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 220571 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 1902520 | 589739 | 585798 | 556672 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2369066 | 687890 | 222530 | 184676 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 200484 | 0 | 61461 | 55014 | |||||||||||||||||||||
balance-sheet.row.total-liab | 6962259 | 1973615 | 948564 | 872087 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 1133697 | 0 | 1167315 | 1212796 | |||||||||||||||||||||
balance-sheet.row.common-stock | 412004 | 103001 | 103001 | 103001 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 3417069 | 809400 | 908158 | 944261 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1880296 | 518678 | 340639 | 247512 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -526061 | 164909 | -1011159 | -1047262 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 13279264 | - | - | - | |||||||||||||||||||||
Total Investments | 490761 | 144421 | 110575 | 101879 | |||||||||||||||||||||
balance-sheet.row.total-debt | 3039609 | 920016 | 200007 | 212744 | |||||||||||||||||||||
balance-sheet.row.net-debt | 1554464 | 584329 | -176833 | -103242 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 40352 | 17045 | 132361 | 156886 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -68238 | -51702 | -24209 | 5956 | |||||||||||||||||||||
cash-flows.row.account-receivables | -55948 | -55948 | -4849 | -8001 | |||||||||||||||||||||
cash-flows.row.inventory | -60036 | -60036 | -7086 | 24058 | |||||||||||||||||||||
cash-flows.row.account-payables | 29466 | 29466 | -12274 | -10101 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 34816 | 34816 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 138353 | 460340 | 113877 | 14918 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 175050 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | -784974 | -784974 | 0 | -670 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -5576 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 12624 | 5576 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 19094 | 12819 | -8583 | 14705 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -848377 | -854652 | -84500 | -62413 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -805689 | -771233 | -50000 | -60000 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | -216772 | 0 | 18505 | -17815 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -10735 | -10735 | -60556 | -50717 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -116653 | -116653 | -100355 | -85236 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 1680968 | -16539 | -3217 | -2530 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 614060 | 614060 | -195623 | -216298 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 18113 | 18113 | 13210 | 11125 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | -41153 | -41153 | 60854 | -10142 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1485145 | 335687 | 376840 | 315986 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1526298 | 376840 | 315986 | 326128 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 175050 | 181325 | 327767 | 257444 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 92553 | 98828 | 239226 | 180996 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1603671 | 1603672 | 1518619 | 1296163 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 325131 | 391305 | 288353 | 253009 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1278540 | 1212367 | 1230266 | 1043154 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 294187 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 546961 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 1180111 | 1034297 | 1098709 | 912191 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1505242 | 1425602 | 1387062 | 1165200 | |||||||||||||||||||||
income-statement-row.row.interest-income | 11454 | 11455 | 8110 | 6149 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 263138 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 107704 | 178070 | 133029 | 155686 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 23534 | 28134 | 132361 | 156886 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7924 | 7924 | 33647 | 32800 | |||||||||||||||||||||
income-statement-row.row.net-income | 12905 | 17045 | 98714 | 124086 |
Häufig gestellte Frage
Wie hoch ist die Astellas Pharma Inc. (ALPMF) Gesamtvermögen?
Astellas Pharma Inc. (ALPMF) Gesamtvermögen ist 3569603000000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 836534000000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.797.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 51.622.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.008.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.067.
Was ist der Astellas Pharma Inc. (ALPMF) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 17045000000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 920016000000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 1034297000000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 335687000000.000.